N‐terminal heterogeneity of parenchymal and vascular amyloid‐β deposits in Alzheimer’s disease
出版年份 2020 全文链接
标题
N‐terminal heterogeneity of parenchymal and vascular amyloid‐β deposits in Alzheimer’s disease
作者
关键词
-
出版物
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-06-05
DOI
10.1111/nan.12637
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer’s disease
- (2019) Eleni Gkanatsiou et al. NEUROSCIENCE LETTERS
- Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer’s disease
- (2019) Oliver Wirths et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition
- (2018) Erwin Cabrera et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)
- (2018) Stephen Salloway et al. Alzheimers Research & Therapy
- The metalloprotease ADAMTS4 generates N-truncated Aβ4–x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer’s disease
- (2018) Susanne Walter et al. ACTA NEUROPATHOLOGICA
- Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8
- (2018) Ibtisam Baghallab et al. JOURNAL OF ALZHEIMERS DISEASE
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
- (2017) David L. Brody et al. Alzheimers Research & Therapy
- N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
- (2017) Oliver Wirths et al. Alzheimers Research & Therapy
- Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
- (2017) Norelle C. Wildburger et al. Scientific Reports
- Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity
- (2016) Sathish Kumar et al. ACTA NEUROPATHOLOGICA
- Spontaneous cleavage of proteins at serine and threonine is facilitated by zinc
- (2016) Brian Lyons et al. AGING CELL
- Solid-Phase Synthesis and Characterization of N-Terminally Elongated Aβ−3-x-Peptides
- (2016) Isaak Beyer et al. CHEMISTRY-A EUROPEAN JOURNAL
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation
- (2016) Jeffrey A. Blair et al. PLoS One
- Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
- (2015) Yvonne Bouter et al. ACTA NEUROPATHOLOGICA
- Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies
- (2015) Gabriela A. N. Crespi et al. Scientific Reports
- Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
- (2014) Andrew D. Watt et al. ACTA NEUROPATHOLOGICA
- Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
- (2014) Thomas A. Bayer et al. ACTA NEUROPATHOLOGICA
- The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes
- (2014) Hoang S. Nhan et al. ACTA NEUROPATHOLOGICA
- Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphismsin Vitroand in Alzheimer Disease Brain
- (2014) Asa Hatami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Truncated and modified amyloid-beta species
- (2014) Markus P Kummer et al. Alzheimers Research & Therapy
- Analysis of Amino-Terminal Variants of Amyloid-β Peptides by Capillary Isoelectric Focusing Immunoassay
- (2013) Ute Haußmann et al. ANALYTICAL CHEMISTRY
- Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease
- (2013) Anika Saul et al. NEUROBIOLOGY OF AGING
- Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
- (2013) Luke A. Miles et al. Scientific Reports
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
- (2012) Sascha Weggen et al. Alzheimers Research & Therapy
- Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains
- (2012) Brenda D Moore et al. Alzheimers Research & Therapy
- Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease
- (2011) Sathish Kumar et al. EMBO JOURNAL
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease
- (2010) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Iowa Variant of Familial Alzheimer’s Disease
- (2010) Yasushi Tomidokoro et al. AMERICAN JOURNAL OF PATHOLOGY
- The Genetics of Alzheimer Disease: Back to the Future
- (2010) Lars Bertram et al. NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started